These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27001139)

  • 1. Mitragynine (Kratom) - monitoring in sports drug testing.
    Guddat S; Görgens C; Steinhart V; Schänzer W; Thevis M
    Drug Test Anal; 2016 Nov; 8(11-12):1114-1118. PubMed ID: 27001139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Evaluation of ion mobility spectrometry for the detection of mitragynine in kratom products".
    Fuenffinger N; Ritchie M; Ruth A; Gryniewicz-Ruzicka C
    J Pharm Biomed Anal; 2017 Feb; 134():282-286. PubMed ID: 27951469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS-MS method for mitragynine and 7-hydroxymitragynine in hair and its application in authentic hair samples of suspected kratom abusers.
    Rhee J; Shin I; Kim J; Lee J; Cho B; Kim J; Park M; Kim E
    J Anal Toxicol; 2024 Jul; 48(6):429-438. PubMed ID: 38780234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism studies of the Kratom alkaloid speciociliatine, a diastereomer of the main alkaloid mitragynine, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry.
    Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
    Anal Bioanal Chem; 2011 Mar; 399(8):2747-53. PubMed ID: 21249338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abuse potential and adverse cognitive effects of mitragynine (kratom).
    Yusoff NH; Suhaimi FW; Vadivelu RK; Hassan Z; Rümler A; Rotter A; Amato D; Dringenberg HC; Mansor SM; Navaratnam V; Müller CP
    Addict Biol; 2016 Jan; 21(1):98-110. PubMed ID: 25262913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral Flow Assessment and Unanticipated Toxicity of Kratom.
    Smith LC; Lin L; Hwang CS; Zhou B; Kubitz DM; Wang H; Janda KD
    Chem Res Toxicol; 2019 Jan; 32(1):113-121. PubMed ID: 30380840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine.
    Papsun DM; Chan-Hosokawa A; Friederich L; Brower J; Graf K; Logan B
    J Anal Toxicol; 2019 Sep; 43(8):615-629. PubMed ID: 31424079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mitragynine and metabolites in human urine for detecting the use of the psychoactive plant kratom.
    Le D; Goggin MM; Janis GC
    J Anal Toxicol; 2012; 36(9):616-25. PubMed ID: 23024321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico investigation of mitragynine and 7-hydroxymitragynine metabolism.
    Limpanuparb T; Noorat R; Tantirungrotechai Y
    BMC Res Notes; 2019 Jul; 12(1):451. PubMed ID: 31331383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation, and application of an LC-MS/MS method for mitragynine and 7-hydroxymitragynine analysis in hair.
    Meier U; Mercer-Chalmers-Bender K; Scheurer E; Dussy F
    Drug Test Anal; 2020 Feb; 12(2):280-284. PubMed ID: 31833662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry.
    Lu S; Tran BN; Nelsen JL; Aldous KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2499-505. PubMed ID: 19577523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual banned-substance review: Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2019 Jan; 11(1):8-26. PubMed ID: 30488582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kratom alkaloids and O-desmethyltramadol in urine of a "Krypton" herbal mixture consumer.
    Arndt T; Claussen U; Güssregen B; Schröfel S; Stürzer B; Werle A; Wolf G
    Forensic Sci Int; 2011 May; 208(1-3):47-52. PubMed ID: 21112167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual banned-substance review: the Prohibited List 2008-analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2009 Jan; 1(1):4-13. PubMed ID: 20355153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
    Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
    J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Mitragynine and Speciociliatine in Umbilical Cord by LC-MS-MS for Detecting Prenatal Exposure to Kratom.
    Hughs M; Kish-Trier E; O'Brien A; McMillin GA
    J Anal Toxicol; 2023 Jan; 46(9):957-964. PubMed ID: 36047661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitragynine concentrations in two fatalities.
    Domingo O; Roider G; Stöver A; Graw M; Musshoff F; Sachs H; Bicker W
    Forensic Sci Int; 2017 Feb; 271():e1-e7. PubMed ID: 28089300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.
    Hughes RL
    Forensic Sci Med Pathol; 2019 Mar; 15(1):110-113. PubMed ID: 30498933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic and clinical assessment of kratom.
    White CM
    Am J Health Syst Pharm; 2018 Mar; 75(5):261-267. PubMed ID: 29255059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of emerging patterns of drug misuse in sports via wastewater monitoring: A mini-review and potential strategies.
    Chang WC; Hsu MC; Liao PC
    Environ Pollut; 2023 Sep; 333():122087. PubMed ID: 37348696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.